Working to Eradicate Gynecologic Cancers

Understanding the rationale and utilizationof PARP inhibitors and anti-angiogenesis therapy in gynecologic malignancies

Friday, March 21, 2014: 3:25 PM
Room 13-16 (Tampa Convention Center)
K. Elliott
Gillette Center for Gynecologic Oncology/ Massachusetts General Hospital, Boston, MA